In analysis of the whole cohort (LSP + HSP patients) CTNNB1 mutations were noted only in patients of the HSP group and they demonstrated a weak negative correlation with leukocyte fraction (p = 3.8 × 10−2 on Wilcoxon test). Here, CTNNB1 is linked to hereditary spastic paraplegia.